| Literature DB >> 31515419 |
Zhenlan Li1, Jie Zhuang2, Yan Jiang1, Guiping Xiao1, Kuncheng Jie1, Tian Wang1, Wenhan Yin1, Yu Zhang3, Zhen Wang2.
Abstract
INTRODUCTION: Qigong exercise offers a potentially safe, low-cost and effective mind-body rehabilitative intervention for mitigating the problem of gait interruption among patients with Parkinson's disease (PD) who have frequent freezing of gait (FOG) episodes. However, its clinical effects have not been established. This paper describes the trial protocol of evaluating the clinical efficacy of a newly developed Integrated Qigong in improving gait among patients with PD who have FOG. METHODS AND ANALYSIS: A single-blind randomised controlled trial is designed to compare Integrated Qigong and balance training with an attention control. Participants will be patients with mild to moderate PD who experience FOG and are recruited from local communities in Shanghai, China. Participants will be randomly allocated to one of the three groups: Integrated Qigong group, a balance exercise intervention group, or control group. The total number of participants will be 126, and masked assessments will be made at baseline, 12 weeks (end of intervention) and 12-week follow-up. Both Integrated Qigong group and balance training group will receive a group-based exercise intervention that meets three times per week, 60 min in duration, for 12 weeks. The control group will receive a 60 min weekly group session and monthly health education. The primary outcomes are gait parameters (stride length, gait velocity, stride time variability) and occurrence of FOG. The secondary outcomes are postural instability, walking disability, falling, fear of falling and quality of life. ETHICS AND DISSEMINATION: This study has been approved by the Ethics Committee of Shanghai University of Sport and registered at China Clinical Trial Registry. Participants will sign informed consent prior to the participation of the trial. The findings of the study will be published in peer-reviewed academic journals and disseminated to PD support groups, medical community and media. TRIAL REGISTRATION NUMBER: ChiCTR1800016570. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: exercise; gait interruption; movement disorder; neurodegenerative disease
Year: 2019 PMID: 31515419 PMCID: PMC6747653 DOI: 10.1136/bmjopen-2018-028869
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Flow diagram of study design.
Figure 2Twelve forms of Integrated Qigong exercise. (A) Form 1: Xu exercise. (B) Form 2: Chui exercise. (C) Form 3: Raising the tiger’s paws. (D) Form 4: Holding the hands high with palms up to regulate the internal organ. (E) Form 5: Drawing a bow. (F) Form 6: Posing as an archer shooting both left and right handed. (G) Form 7: Pulling nine cows by their tails. (H) Form 8: Rub. backbone. (I) Form 9: Swaying like a bear. (J) Form 10: Picking fruit. (K) Form 11: Golden rooster heralds the dawn. (L) Form 12: Flying like a bird.
Demographic and clinical characteristics of the study participants*
| Integrated Qigong | Balance training | Control | |
| Age (year) | |||
| Gender (male%:female%) | |||
| Body mass index† (kg/m2) | |||
| Height (cm) | |||
| Hoehn and Yahr stage, n (%) | |||
| 1–1.5 | |||
| 2–2.5 | |||
| ≥3 | |||
| Age of onset (year) | |||
| Duration of disease (year) | |||
| Score of MoCA (/30) | |||
| Antiparkinsonian medications taken, n | |||
| Levodopa or carbidopa | |||
| Pramipexole or ropinirole | |||
| Other | |||
| Self-reported health status‡, n (%) | |||
| Poor or fair | |||
| Good | |||
| Very good or excellent | |||
| Family situation, n (%) | |||
| Living along | |||
| Living with husband/wife | |||
| Living with husband/wife and children | |||
| Score for self-reported habitual physical activity§ | |||
| Falls in previous 6 months, n |
*Mean values (SD). The χ2 test is used for categorical variables, and one-way analysis of variance for continuous variables.
†The body mass index is the weight in kilograms divided by the square of the height in metres.
‡Self-reported health status included cardiovascular disease, lung disease, osteoporosis, arthritis, liver and kidney disease, low back pain and cancer; the number of conditions per participant ranged from 0 to 9.
§This is measured by the Physical Activity Scale for the Elderly,46 with higher scores indicating higher levels of habitual physical activity.
MoCA, Montreal Cognitive Assessment.
Changes over time within and between control and experimental groups
| Group | Baseline* | 12 weeks* | Follow-up* | Mean difference at 12 weeks† | Mean difference at follow-up |
|
|
|
| Primary outcome | ||||||||
| Stride length (cm) | ||||||||
| Integrated Qigong | ||||||||
| Balance training | ||||||||
| Control | ||||||||
| Gait velocity (cm/s) | ||||||||
| Integrated Qigong | ||||||||
| Balance training | ||||||||
| Control | ||||||||
| Cadence | ||||||||
| Integrated Qigong | ||||||||
| Balance training | ||||||||
| Control | ||||||||
| Stride time | ||||||||
| Integrated Qigong | ||||||||
| Balance training | ||||||||
| Control | ||||||||
| NFOGQ | ||||||||
| Integrated Qigong | ||||||||
| Balance training | ||||||||
| Control | ||||||||
| Secondary outcome | ||||||||
| FGA | ||||||||
| Integrated Qigong | ||||||||
| Balance training | ||||||||
| Control | ||||||||
| MDS-UPDRS Part III | ||||||||
| Integrated Qigong | ||||||||
| Balance training | ||||||||
| Control | ||||||||
| Mini-BESTest | ||||||||
| Integrated Qigong | ||||||||
| Balance training | ||||||||
| Control | ||||||||
| Total falls, n | ||||||||
| Integrated Qigong | ||||||||
| Balance training | ||||||||
| Control | ||||||||
| MFES | ||||||||
| Integrated Qigong | ||||||||
| Balance training | ||||||||
| Control | ||||||||
| PDQ-39 | ||||||||
| Integrated Qigong | ||||||||
| Balance training | ||||||||
| Control |
*Mean values (SD).
†Mean difference (SE).
CV, coefficient of variation; FGA, Functional Gait Assessment; MDS-UPDRS Part III, Movement Disorder Society Unified Parkinson’s Disease Rating Scale, motor subscale; MFES, Modified Falls Efficacy Scale; Mini-BESTest, Mini-Balance Evaluation Systems Test; NFOGQ, New Freezing of Gait Questionnaire; PDQ-39, 39-item Parkinson’s Disease Questionnaire.